BACKGROUND: The need for routine left subclavian artery (LSCA) revascularization when this vessel is covered during thoracic endovascular aortic repair remains controversial. We report our results with a selective LSCA revascularization strategy during thoracic endovascular aortic repair. METHODS: Between May 2002 and March 2010, 287 thoracic endovascular aortic repair procedures were performed at our institution. LSCA coverage occurred in 145 (51%), which form the basis of this report. RESULTS: Left subclavian artery revascularization was performed in 32 patients (22%) through a left common carotid-LSCA bypass. Indications for selective LSCA revascularization included spinal cord protection in 10, patent pedicled left internal mammary artery graft in 9, left arm ischemia after LSCA coverage in 5, origin of the left vertebral artery from the arch in 4, dialysis access in the left arm in 2, and vertebrobasilar insufficiency in 2. There were no instances of dominant left vertebral artery. The revascularized and non-revascularized groups had similar rates of death (6.3% vs 1.8%; p=0.21), stroke (3.1% vs 3.5%; p>0.99), permanent paraplegia or paraparesis (3.1% vs 0%; p=0.22), and type II endoleak (4.3% vs 6.5%; p>0.99). There were no instances of ischemic stroke related to left posterior circulation hypoperfusion. Four complications of carotid-subclavian bypass occurred in 3 patients (9.4%). CONCLUSIONS: Selective LSCA revascularization is safe and does not appear to increase the risk of neurologic events. Further, subclavian revascularization is not without complications, which should be considered with regards to a nonselective revascularization strategy.
BACKGROUND: The need for routine left subclavian artery (LSCA) revascularization when this vessel is covered during thoracic endovascular aortic repair remains controversial. We report our results with a selective LSCA revascularization strategy during thoracic endovascular aortic repair. METHODS: Between May 2002 and March 2010, 287 thoracic endovascular aortic repair procedures were performed at our institution. LSCA coverage occurred in 145 (51%), which form the basis of this report. RESULTS: Left subclavian artery revascularization was performed in 32 patients (22%) through a left common carotid-LSCA bypass. Indications for selective LSCA revascularization included spinal cord protection in 10, patent pedicled left internal mammary artery graft in 9, left arm ischemia after LSCA coverage in 5, origin of the left vertebral artery from the arch in 4, dialysis access in the left arm in 2, and vertebrobasilar insufficiency in 2. There were no instances of dominant left vertebral artery. The revascularized and non-revascularized groups had similar rates of death (6.3% vs 1.8%; p=0.21), stroke (3.1% vs 3.5%; p>0.99), permanent paraplegia or paraparesis (3.1% vs 0%; p=0.22), and type II endoleak (4.3% vs 6.5%; p>0.99). There were no instances of ischemic stroke related to left posterior circulation hypoperfusion. Four complications of carotid-subclavian bypass occurred in 3 patients (9.4%). CONCLUSIONS: Selective LSCA revascularization is safe and does not appear to increase the risk of neurologic events. Further, subclavian revascularization is not without complications, which should be considered with regards to a nonselective revascularization strategy.
Authors: Elliot L Chaikof; Jan D Blankensteijn; Peter L Harris; Geoffrey H White; Christopher K Zarins; Victor M Bernhard; Jon S Matsumura; James May; Frank J Veith; Mark F Fillinger; Robert B Rutherford; K Craig Kent Journal: J Vasc Surg Date: 2002-05 Impact factor: 4.268
Authors: Syed M Rehman; Joshua A Vecht; Ryan Perera; Rozh Jalil; Srdjan Saso; Emaddin Kidher; Andrew Chukwuemeka; Nicholas J Cheshire; Mohamad S Hamady; Ara Darzi; Richard G Gibbs; Jon R Anderson; Thanos Athanasiou Journal: Ann Vasc Surg Date: 2010-10 Impact factor: 1.466
Authors: Albert T Cheung; Alberto Pochettino; Michael L McGarvey; Jehangir J Appoo; Ronald M Fairman; Jeffrey P Carpenter; William G Moser; Edward Y Woo; Joseph E Bavaria Journal: Ann Thorac Surg Date: 2005-10 Impact factor: 4.330
Authors: G Chad Hughes; Sean M Lee; Mani A Daneshmand; Syamal D Bhattacharya; Judson B Williams; Sonny W Tucker; Richard L McCann Journal: Ann Thorac Surg Date: 2010-07 Impact factor: 4.330
Authors: Umit Karadeniz; Ozcan Erdemli; Mehmet Ali Ozatik; Bülent Yamak; Abid Demirci; Seref A Küçüker; Ahmet Saritaş; Oğuz Taşdemir Journal: Ann Thorac Surg Date: 2005-01 Impact factor: 4.330
Authors: David G Cooper; Stewart R Walsh; Umar Sadat; Ayesha Noorani; Paul D Hayes; Jonathan R Boyle Journal: J Vasc Surg Date: 2009-02-15 Impact factor: 4.268
Authors: Rens R B Varkevisser; Nicholas J Swerdlow; Livia E V M de Guerre; Kirsten Dansey; Chun Li; Patric Liang; Christopher A Latz; Mathijs T Carvalho Mota; Hence J M Verhagen; Marc L Schermerhorn Journal: J Endovasc Ther Date: 2020-05-21 Impact factor: 3.487
Authors: Salvatore T Scali; Catherine K Chang; Stephen G Pape; Robert J Feezor; Scott A Berceli; Thomas S Huber; Adam W Beck Journal: J Vasc Surg Date: 2013-05-25 Impact factor: 4.268
Authors: Ehsan Benrashid; Hanghang Wang; Nicholas D Andersen; Jeffrey E Keenan; Richard L McCann; G Chad Hughes Journal: J Vasc Surg Date: 2016-07-18 Impact factor: 4.268
Authors: G Chad Hughes; Asvin M Ganapathi; Jeffrey E Keenan; Brian R Englum; Jennifer M Hanna; Matthew A Schechter; Hanghang Wang; Richard L McCann Journal: Ann Thorac Surg Date: 2014-10-01 Impact factor: 4.330
Authors: Hamdy Awad; Mohamed Ehab Ramadan; Hosam F El Sayed; Daniel A Tolpin; Esmerina Tili; Charles D Collard Journal: Can J Anaesth Date: 2017-10-10 Impact factor: 5.063
Authors: Nicholas D Andersen; Judson B Williams; Jennifer M Hanna; Asad A Shah; Richard L McCann; G Chad Hughes Journal: J Vasc Surg Date: 2012-11-24 Impact factor: 4.268
Authors: Shahin Hajibandeh; Shahab Hajibandeh; Stavros A Antoniou; Francesco Torella; George A Antoniou Journal: Cochrane Database Syst Rev Date: 2016-04-27